210 related articles for article (PubMed ID: 25957594)
1. Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population.
Khaliq W; Qayyum R; Clough J; Vaidya D; Wolff AC; Becker DM
Breast Cancer Res Treat; 2015 Jun; 151(2):465-74. PubMed ID: 25957594
[TBL] [Abstract][Full Text] [Related]
2. Systemic Lupus Erythematosus and Mortality in Elderly Patients With Early Breast Cancer.
Bruera S; Lei X; Pundole X; Zhao H; Giordano SH; Vinod S; Suarez-Almazor ME
Arthritis Care Res (Hoboken); 2023 Mar; 75(3):559-568. PubMed ID: 34558796
[TBL] [Abstract][Full Text] [Related]
3. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection.
Shah AA; Igusa T; Goldman D; Li J; Casciola-Rosen L; Rosen A; Petri M
Arthritis Res Ther; 2021 Feb; 23(1):64. PubMed ID: 33632283
[TBL] [Abstract][Full Text] [Related]
4. Do traditional Gail model risk factors account for increased breast cancer in women with lupus?
Bernatsky S; Ramsey-Goldman R; Boivin JF; Joseph L; Moore AD; Rajan R; Clarke A
J Rheumatol; 2003 Jul; 30(7):1505-7. PubMed ID: 12858448
[TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
6. Risk of retinal vein occlusion in patients with systemic lupus erythematosus: a population-based cohort study.
Yen YC; Weng SF; Chen HA; Lin YS
Br J Ophthalmol; 2013 Sep; 97(9):1192-6. PubMed ID: 23832964
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of malignancy in patients with systemic lupus erythematosus.
Ramsey-Goldman R; Mattai SA; Schilling E; Chiu YL; Alo CJ; Howe HL; Manzi S
J Investig Med; 1998 Jun; 46(5):217-22. PubMed ID: 9676054
[TBL] [Abstract][Full Text] [Related]
8. Increased Risk of Autism Spectrum Disorders in Children Born to Women With Systemic Lupus Erythematosus: Results From a Large Population-Based Cohort.
Vinet É; Pineau CA; Clarke AE; Scott S; Fombonne É; Joseph L; Platt RW; Bernatsky S
Arthritis Rheumatol; 2015 Dec; 67(12):3201-8. PubMed ID: 26315754
[TBL] [Abstract][Full Text] [Related]
9. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of subarachnoid hemorrhage in patients with systemic lupus erythematosus: a nationwide population-based study.
Chang YS; Liu CJ; Chen WS; Lai CC; Wang SH; Chen TJ; Tzeng CH; Tsai CY; Wang SJ
Arthritis Care Res (Hoboken); 2013 Apr; 65(4):601-6. PubMed ID: 22965820
[TBL] [Abstract][Full Text] [Related]
11. Incidence of cancer in a cohort of Spanish patients with systemic lupus erythematosus.
Hidalgo-Conde A; de Haro Liger M; Abarca-Costalago M; Álvarez Pérez M; Valdivielso-Felices P; González-Santos P; Fernández-Nebro A
Reumatol Clin; 2013; 9(6):359-64. PubMed ID: 24099959
[TBL] [Abstract][Full Text] [Related]
12. Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study.
Lin C; Lin SW; Weng SF; Lin YS
Audiol Neurootol; 2013; 18(2):95-100. PubMed ID: 23257626
[TBL] [Abstract][Full Text] [Related]
13. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
14. Cancer screening in patients with systemic lupus erythematosus.
Bernatsky SR; Cooper GS; Mill C; Ramsey-Goldman R; Clarke AE; Pineau CA
J Rheumatol; 2006 Jan; 33(1):45-9. PubMed ID: 16331804
[TBL] [Abstract][Full Text] [Related]
15. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
Lin YC; Yen JH; Chang SJ; Lin YC
Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
[TBL] [Abstract][Full Text] [Related]
16. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and incidence of systemic lupus erythematosus and associated outcomes in the 2009-2016 US Medicare population.
Li S; Gong T; Peng Y; Nieman KM; Gilbertson DT
Lupus; 2020 Jan; 29(1):15-26. PubMed ID: 31726936
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer stage at time of detection in women with systemic lupus erythematosus.
Bernatsky S; Clarke A; Ramsey-Goldman R; Boivin JF; Joseph L; Rajan R; Manzi S
Lupus; 2004; 13(6):469-72. PubMed ID: 15303575
[TBL] [Abstract][Full Text] [Related]
19. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
Somers E; Magder LS; Petri M
J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
